Changes in albumin concentrations in the synovial fluid are often associated with inflammatory conditions such as OA or rheumatoid arthritis, with levels typically decreasing, rendering it a potential biomarker in clinical settings [85,86]. This evidence concerns the gene ALB and rheumatoid arthritis.